Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
NSRX2 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in NASUS PHARMA LTD
Yes. Balyasny Asset Management holds 898,473 shares of NSRX (Nasus Pharma), worth $3.1M, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Balyasny Asset Management has held NSRX since Q1 2026, across 2 quarterly 13F filings.
Current Value
$3.1M
Current Shares
898,473
Total Value Change
+$1.2M
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NSRX: Hudson Bay Capital Management LP, HRT FINANCIAL LP, CITADEL ADVISORS LLC, XTX Topco Ltd